Alterations in the cutaneous microbiome of patients with psoriasis and psoriatic arthritis reveal similarities between non lesional and lesional skin Annals of the Rheumatic Diseases Many treatment guidelines for psoriasis rely heavily on body surface area (BSA) involvement to determine disease severity and eligibility for systemic therapies like biologics. Traditionally, patients with less than 10% BSA involvementespecially Biologic and Small Molecule Therapies for Moderate to Severe Psoriasis: Focus on Psoriasis Comorbidities BioDrugs Springer Nature Link Inflammatory memory in psoriasis: From remission to recurrence Journal of Allergy and Clinical Immunology Healing the Gut to Treat Psoriasis? Next Steps in Dermatology